229 related articles for article (PubMed ID: 33826785)
1. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation.
Elkamshoushi AM; Romisy D; Omar SS
J Cosmet Dermatol; 2022 Feb; 21(2):657-668. PubMed ID: 33826785
[TBL] [Abstract][Full Text] [Related]
2. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
Hawwam SA; Ismail M; El-Attar YA
Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
Debasmita B; Raj C; Ishan A; Ipsita D
J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
[TBL] [Abstract][Full Text] [Related]
4. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation.
Agamia N; Apalla Z; Salem W; Abdallah W
J Dermatolog Treat; 2021 Nov; 32(7):819-826. PubMed ID: 31908179
[TBL] [Abstract][Full Text] [Related]
5. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
6. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
Lueangarun S; Namboonlue C; Tempark T
J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
[TBL] [Abstract][Full Text] [Related]
7. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy.
Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913
[TBL] [Abstract][Full Text] [Related]
9. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
[TBL] [Abstract][Full Text] [Related]
11. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
[TBL] [Abstract][Full Text] [Related]
12. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
[TBL] [Abstract][Full Text] [Related]
14. A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
Kwon HH; Ohn J; Suh DH; Park HY; Choi SC; Jung JY; Kwon IH; Park GH
J Dermatolog Treat; 2017 Mar; 28(2):155-159. PubMed ID: 27346606
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
17. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
18. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
Laothaworn V; Juntongjin P
J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
[No Abstract] [Full Text] [Related]
19. Combining Low Power Fractional CO
Esmat S; Z Elramly A; Shahin D; Hilal RF
Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
[TBL] [Abstract][Full Text] [Related]
20. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser.
Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S
Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
